Numera Cas: 168273-06-1 Fuafuaga Molecular: C22H21Cl3N4O
| Lisi Lisi | 154.7 °C |
| Malosi | 1.299 |
| taimi e teu ai | leai ni tapula'a. |
| solubility | Solu i le DMSO (e o'o i le 20 mg/ml) po'o le Ethanol (e o'o atu i le 20 mg/ml).dimethyl sulfoxide ma e le mafai ona solu ile benzene po'o le hexane. |
| gaioiga fa'apitoa | N/A |
| Fa'aaliga | pa'epa'e pa'epa'e lanu samasama malamalama |
| Mama | ≥98% |
ose fa'afeagai fa'afeagai mo le fa'afofoga cannabinoid (CB1).E galue e ala i le polokaina filifilia o le CB1 o loʻo maua i totonu o le faiʻai ma i totonu o totoga lautele e taua i le kulukose ma le lipid metabolism, e aofia ai le adipose tissue, ate, gastrointestinal tract, ma maso.O le mea lea, o loʻo iai se togafitiga faʻapitoa mo le gaʻo ma le faʻalavelave cardiovascular.I le avea ai o se vailaʻau antiobesity anorectic, na faʻaaogaina e fai ma faʻaopoopoga i meaʻai ma faʻamalositino mo tagata mamaʻi poʻo le mamafa o loʻo iai faʻalavelave faʻalavelave i Europa i le 2006. Ae ui i lea, o aʻafiaga leaga e aofia ai le suicidality, atuatuvale, ma le popole na lipotia, e faʻavae i luga o le rimonadant na faaui i tua. i le lalolagi atoa i le 2008.
Andogenous cannabinoids e fesoʻotaʻi ma le faʻafiafiaga o le nicotine, e pei o le cannabinoid receptorblocker, o loʻo faʻataʻitaʻiina foi e avea o se togafitiga e teteʻe ai i le ulaula.
ose immunomodulatory CB1 fa'afofoga fa'afeagai agonist
Fesili muamua ile Fomai
